Expression and clinical significance of miR-17-5p in tumor tissues of patients with colorectal cancer

Zheng Liu,Mengmeng Ji,Fangtong Jin,Feng Jiang,Xiaoping Liu

DOI: https://doi.org/10.21037/jgo-22-1185

2022-12-29

Journal of Gastrointestinal Oncology

Abstract:Keywords: Colorectal cancer (CRC); miR-17-5p; proliferation; invasion; apoptosis

oncology,gastroenterology & hepatology

What problem does this paper attempt to address?

Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer

Ping Li,Jia-Xun Cai,Fei Han,Jie Wang,Jia-Jie Zhou,Kai-Wen Shen,Liu-Hua Wang

DOI: https://doi.org/10.4251/wjgo.v12.i4.492

2020-01-01

World Journal of Gastrointestinal Oncology

Abstract:BACKGROUND The relationship between microRNAs, such as miR-654-5p and miR-376b-3p, and the prognosis of colon cancer has not been studied until now. AIM To evaluate the expression levels of miR-654-5p and miR-376b-3p and their clinical significance in colon cancer. METHODS RT-qPCR was performed to evaluate miR-654-5p and miR-376b-3p expression in 34 pairs of colon cancer and adjacent noncancerous tissues. Subsequently, the association of miR-654-5p and miR-376b-3p expression with clinical factors or the survival of patients suffering from colon cancer was determined by using The Cancer Genome Atlas. RESULTS miR-654-5p was upregulated and miR-376b-3p was downregulated in colon cancer tissues compared with adjacent noncancerous tissues (P < 0.001). Increased miR-654-5p and decreased miR-376b-3p expression levels were significantly associated with metastasis and clinical stage. Moreover, a univariate analysis demonstrated that colon cancer patients with high miR-654-5p or low miR-376b-3p expression (P = 0.044 and 0.007, respectively) had a poor overall survival rate. A multivariate analysis identified high miR-654-5p expression and low miR-376b-3p expression as independent predictors of poor survival in colon cancer patients. CONCLUSION Upregulated miR-654-5p and downregulated miR-376b-3p may be associated with tumour progression in colon cancer, and these microRNAs may serve as independent prognostic markers for colon cancer.
Elevated Oncofoetal Mir-17-5p Expression Regulates Colorectal Cancer Progression by Repressing Its Target Gene P130

Yanlei Ma,Peng Zhang,Feng Wang,Huizhen Zhang,Yongzhi Yang,Chenzhang Shi,Yang Xia,Jiayuan Peng,Weijie Liu,Zhe Yang,Huanlong Qin

DOI: https://doi.org/10.1038/ncomms2276

IF: 16.6

2012-01-01

Nature Communications

Abstract:MicroRNAs (miRNAs) are essential for regulating normal embryonic development and carcinogenesis. Here we report that miR-17-5p, an oncofoetal miRNA, is a key regulator of colorectal cancer progression. We show that miR-17-5p is an oncogenic miRNA that regulates tumorigenesis and progression by targeting the gene encoding P130 and subsequently activating the Wnt/β-catenin pathway. Using specimens from two large cohorts of colorectal cancer patients, we found that patients whose tumours had high miR-17-5p expression had shorter overall survival rates but showed a better response to adjuvant chemotherapy than did patients whose tumours had low miRNA expression. We also observed a strong inverse correlation between miR-17-5p and P130 expression. The current findings suggest that miR-17-5p is a crucial determinant of colorectal cancer progression.
The expression and clinical significance of miR-647 in colon cancer cells

Shaoqing Liu,Chenxiang He,Weiping Li,Dingding Qu,Jian Zhang,Shisen Li,Guosheng Wu,Jianyong Zheng

DOI: https://doi.org/10.3969/j.issn.1672-4992.2017.04.01

2017-01-01

Abstract:Objective:To analyze the expression of miR-647 in colon cancer tissues and colon cancer cell lines, explore the influences of miR-647 on cell proliferation and migration,and discuss the possible mechanism.Meth-ods:Detecting the expression of miR-647 in 17 pairs of colon cancer tissues and adjacent tissues by Real -time quantitative Polymerase Chain Reaction (qPCR).Analyzing the expression of miR-647 in HIEC and HT-29 by qPCR.Transfecting miR-647 antagomir and negative control into colon cancer cells by using the LipofectaminTM RNAiMAX,and then testing the cell proliferation and migration by MTT and wound healing assay respectively.Re-sults:qPCR showed that miR-647 was significantly increased in tumor tissue of patients with colon cancer compared with the adjacent tissues.And miR-647 was also notably increased in colon cancer cell line (HT-29 )compared with the HIEC.MTT and wound healing assay results showed that miR-647 antagomir significantly inhibited the pro-liferation and migration of SW480 and SW620 cells.Conclusion:miR-647 participated in the process of colon canc-er development by promoting the proliferation and migration abilities of colon cancer cell lines.
miR-215 expression and its clinical significance in advanced colorectal cancer

WU Xubo,CAO Yiou,PU Wenlan,XIE Yun,LI Donghua

DOI: https://doi.org/10.3969/j.issn.1007-9610.2013.03.013

2013-01-01

Abstract:Objective To investigate the expression and clinical significance of miR-215 in colorectal cancer(CRC).Methods The data of patients with advanced colorectal cancer from Jan to Jun 2007 in our hospital were analyzed.microRNA was extracted from formalin-fixed paraffin-embedded tissue and the levels of miR-215 were quantified by quantitative real-time polymerase chain reaction.Results Forty-two cases with CRC were enrolled(25 males and 17 females).Among them,18 cases had rectal cancer and 24 colon cancer.The levels of miR-215 expression were lower in CRC tissues than in adjacent non-tumor tissues(P<0.001).Patients with slight-decrease of miR-215 levels in CRC tissue had longer survival time(P=0.035) and higher levels of P53 expression(r=0.556,P<0.001).Conclusions miR-215 might be a prognostic biomarker for colorectal cancer.
Biology of Human Tumors miR-2045 p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB 22 A

Yuan Yin,Binbin Zhang,Weili Wang,Bojian Fei,Chao Quan,Jiwei Zhang,Mingxu Song,Zehua Bian,Qifeng Wang,Shujuan Ni,Yaling Hu,Yong Mao,Leyuan Zhou,Yugang Wang,Jian Yu,Xiang Du,Dong Hua,Zhaohui Huang

2014-01-01

Abstract:Purpose: miR-204-5p was found to be downregulated in colorectal cancer tissues in our preliminary microarray analyses. However, the function of miR-204-5p in colorectal cancer remains unknown. We therefore investigated the role, mechanism, and clinical significance of miR-204-5p in colorectal cancer development and progression. Experimental Design:Wemeasured the expression of miR-204-5p and determined its correlation with patient prognoses. Ectopic expression in colorectal cancer cells, xenografts, and pulmonary metastasis models was used to evaluate the effects of miR-204-5p on proliferation, migration, and chemotherapy sensitivity. Luciferase assay and Western blotting were performed to validate the potential targets of miR204-5p after the preliminary screening by a microarray analysis and computer-aided algorithms. Results: miR-204-5p is frequently downregulated in colorectal cancer tissues, and survival analysis showed that the downregulation of miR-204-5p in colorectal cancer was associated with poor prognoses. Ectopic miR-204-5p expression repressed colorectal cancer cell growth both in vitro and in vivo. Moreover, restoring miR-204-5p expression inhibited colorectal cancer migration and invasion and promoted tumor sensitivity to chemotherapy. Mechanistic investigations revealed that RAB22A, a member of the RAS oncogene family, is a direct functional target of miR-204-5p in colorectal cancer. Furthermore, RAB22A protein levels in colorectal cancer tissues were frequently increased and negatively associated withmiR-2045p levels and survival time. Conclusions: Our results demonstrate for the first time that miR-204-5p acts as a tumor suppressor in colorectal cancer through inhibitingRAB22A and revealRAB22A to be anewoncogene andprognostic factor for colorectal cancer. Clin Cancer Res; 20(23); 6187–99. 2014 AACR.
Mir-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.

Yuan Yin,Binbin Zhang,Weili Wang,Bojian Fei,Chao Quan,Jiwei Zhang,Mingxu Song,Zehua Bian,Qifeng Wang,Shujuan Ni,Yaling Hu,Yong Mao,Leyuan Zhou,Yugang Wang,Jian Yu,Xiang Du,Dong Hua,Zhaohui Huang

DOI: https://doi.org/10.1158/1078-0432.ccr-14-1030

IF: 13.801

2014-01-01

Clinical Cancer Research

Abstract:Abstract Purpose: miR-204-5p was found to be downregulated in colorectal cancer tissues in our preliminary microarray analyses. However, the function of miR-204-5p in colorectal cancer remains unknown. We therefore investigated the role, mechanism, and clinical significance of miR-204-5p in colorectal cancer development and progression. Experimental Design: We measured the expression of miR-204-5p and determined its correlation with patient prognoses. Ectopic expression in colorectal cancer cells, xenografts, and pulmonary metastasis models was used to evaluate the effects of miR-204-5p on proliferation, migration, and chemotherapy sensitivity. Luciferase assay and Western blotting were performed to validate the potential targets of miR-204-5p after the preliminary screening by a microarray analysis and computer-aided algorithms. Results: miR-204-5p is frequently downregulated in colorectal cancer tissues, and survival analysis showed that the downregulation of miR-204-5p in colorectal cancer was associated with poor prognoses. Ectopic miR-204-5p expression repressed colorectal cancer cell growth both in vitro and in vivo. Moreover, restoring miR-204-5p expression inhibited colorectal cancer migration and invasion and promoted tumor sensitivity to chemotherapy. Mechanistic investigations revealed that RAB22A, a member of the RAS oncogene family, is a direct functional target of miR-204-5p in colorectal cancer. Furthermore, RAB22A protein levels in colorectal cancer tissues were frequently increased and negatively associated with miR-204-5p levels and survival time. Conclusions: Our results demonstrate for the first time that miR-204-5p acts as a tumor suppressor in colorectal cancer through inhibiting RAB22A and reveal RAB22A to be a new oncogene and prognostic factor for colorectal cancer. Clin Cancer Res; 20(23); 6187–99. ©2014 AACR.
MicroRNA-142-3p Inhibits Tumorigenesis of Colorectal Cancer via Suppressing the Activation of Wnt Signaling by Directly Targeting to β-Catenin

Peng Liu,Fuao Cao,Jinke Sui,Yonggang Hong,Qizhi Liu,XianHua Gao,Haifeng Gong,Liqiang Hao,Zheng Lou,Wei Zhang

DOI: https://doi.org/10.3389/fonc.2020.552944

IF: 4.7

2021-02-10

Frontiers in Oncology

Abstract:Background Altered expression profile of microRNAs (miRNAs) was reported to be associated with colorectal cancer (CRC). The aims of this study are to identify the changed miRNAs in the plasma of CRC patients and explore the underlying mechanism of these miRNAs during tumorigenesis. Methods Plasma miRNA expression profiles were compared between healthy people and CRC patients. MiRNA expression was measured using quantitative real-time PCR. Colony formation and MTT assays were used to test cell proliferation. Luciferase assay, immunohistochemistry and Western blotting were employed to explore the molecular mechanism. Results MiR-142-3p level was found as the most significantly repressed miRNA in CRC patients. Overexpression of miR-142-3p dramatically repressed colony formation and cell proliferation of both HT29 and HCT116 cells while inhibition of miR-142-3p promoted those of the cells. Interestingly, overexpression of miR-142-3p reduced the level and nuclear accumulation of β-catenin. We further observed that miR-142-3p remarkably inhibited the transcriptional activity of β-catenin gene (CTNNB1). However, mutations in the predicted binding sites blocked this inhibition, suggesting that miR-142-3p may directly bind to the mRNA of β-catenin. Conclusion In conclusion, we identified miR-142-3p exerts its function as a tumor suppressor through blocking the activation of Wnt signaling by directly targeting to CTNNB1.

oncology
P53-induced Mir-1249 Inhibits Tumor Growth, Metastasis, and Angiogenesis by Targeting VEGFA and HMGA2

Xiaoxiang Chen,Kaixuan Zeng,Mu Xu,Xiangxiang Liu,Xiuxiu Hu,Tao Xu,Bangshun He,Yuqin Pan,Huiling Sun,Shukui Wang

DOI: https://doi.org/10.1038/s41419-018-1188-3

2019-01-01

Cell Death and Disease

Abstract:MicroRNAs (miRNAs) are important class of functional regulators involved in human cancers development, including colorectal cancer (CRC). Exploring aberrantly expressed miRNAs may provide us with new insights into the initiation and development of CRC by functioning as oncogenes or tumor suppressors. The aim of our study is to discover the expression pattern of miR-1249 in CRC and investigate its clinical significance as well as biological role in CRC progression. In our study, we found that miR-1249 was markedly downregulated in CRC tissues and cell lines, and negatively related to pN stage, pM stage, TNM stage, and overall survival (OS). Moreover, we demonstrated that miR-1249 was a direct transcriptional target of P53 and revealed that P53-induced miR-1249 inhibited tumor growth, metastasis and angiogenesis in vitro and vivo. Additionally, we verified that miR-1249 suppressed CRC proliferation and angiogenesis by targeting VEGFA as well as inhibited CRC metastasis by targeting both VEGFA and HMGA2. Further studying showed that miR-1249 suppressed CRC cell proliferation, migration, invasion, and angiogenesis via VEGFA-mediated Akt/mTOR pathway as well as inhibited EMT process of CRC cells by targeting both VEGFA and HMGA2. Our study indicated that P53-induced miR-1249 may suppress CRC growth, metastasis and angiogenesis by targeting VEGFA and HMGA2, as well as regulate Akt/mTOR pathway and EMT process in the initiation and development of CRC. miR-1249 might be a novel the therapeutic candidate target in CRC treatment.
Clinical and Biological Significance of Mir-378a-3p and Mir-378a-5p in Colorectal Cancer

Hui Li,Sujuan Dai,Tiantian Zhen,Huijuan Shi,Fenfen Zhang,Yang,Lili Kang,Yingjie Liang,Anjia Han

DOI: https://doi.org/10.1016/j.ejca.2013.12.010

IF: 10.002

2014-01-01

European Journal of Cancer

Abstract:To investigate miR-378a-3p and miR-378a-5p expression and their relationships with the clinicopathological features of colorectal cancer (CRC). Our results showed that miR-378a-3p and miR-378a-5p expression were dramatically lower in CRC cell lines and tissues than that in adjacent normal colorectal mucosal tissues, respectively. MiR-378a-3p and miR-378a-5p expression were significantly associated with histological differentiation and TNM stage, respectively. CRC patients with low miR-378a-3p and miR-378a-5p expression had a significantly shorter survival time than those patients with high miR-378a-3p and miR-378a-5p expression (p<0.001, p<0.001), respectively. Univariate and multivariable Cox regression analysis showed that tumour size, TNM stage, miR-378a-3p expression and miR-378a-5p expression were independent prognostic factors for CRC patients. Ectopic miR-378a-3p or miR-378a-5p expression inhibited cellular proliferation and colony formation, induced apoptosis and G1-phase cell cycle arrest in CRC cells, but had no effect on migration and invasion of CRC cells. Furthermore, miR-378a-3p over-expression or down-regulation could inhibit or enhance insulin-like growth factor 1 receptor (IGF1R) expression in CRC cells. There was a significantly negative correlation between IGF1R protein expression and miR-378a-3p expression in CRC tissues. MiR-378a-3p over-expression or down-regulation suppressed or enhanced phosphorylated-ERK1/2 protein level, but had no effect on phosphorylated-Akt protein level. In conclusion, miR-378a-3p and miR-378a-5p expression might play an important role as tumour suppressor gene in the initial stage of carcinogenesis of CRC.
Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets.

Jie-Yu Wang,Jia-Cheng Huang,Gang Chen,Dan-Ming Wei

DOI: https://doi.org/10.3892/mmr.2018.8532

IF: 3.423

2018-01-01

Molecular Medicine Reports

Abstract:For the purpose of demonstrating the clinical value and unraveling the molecular mechanisms of micro RNA (miR)-1-3p in colorectal carcinoma (CRC), the present study collected expression and diagnostic data from Gene Expression Omnibus (GEO), ArrayExpress and existing literature to conduct meta-analyses and diagnostic tests. Furthermore, the potential targets of miR-1-3p were attained from datasets that transfected miR-1-3p into CRC cells, online prediction databases and differentially expressed genes from The Cancer Genome Atlas and literature. Subsequently, bioinformatics analysis was conducted based on the aforementioned selected target genes. As a result, downregulation of miR-1-3p was observed. The combined standardized mean difference was -0.51 with 95% confidence interval (CI) of -0.68 to -0.33 using a fixed effect model, which demonstrated a significant downregulation of miR-1-3p in CRC. The combined sensitivity, specificity, positive likelihood ratio, negative likelihood ratio diagnostic score and odds ratio were 0.74 (95%CI: 0.48, 0.90), 0.75 (95%CI: 0.35, 0.94), 2.94 (95%CI: 1.01, 8.55), 0.34 (95%CI: 0.19, 0.60), 2.15 (95%CI: 1.06, 3.23) and 8.57 (95%CI: 2.89, 25.36). The summarized receiver operating characteristic curve demonstrated that the area under the curve was 0.81. In bioinformatics analyses based on 30 promising targets, the most enriched terms in Gene Ontology were positive regulation of transcription from RNA polymerase II promoter, extracellular region and transcription factor binding. Kyoto Encyclopedia of Genes and Genomes pathway analysis highlighted the pathway termed cytokine-cytokine receptor interaction. In protein-protein interaction analysis, platelet factor 4 was selected as the hub gene. To conclude, miR-1-3p is downregulated in CRC and likely suppresses CRC via multiple biological approaches, which indicates the diagnostic potential and tumor suppressive efficacy.
Expression Level and Potential Target Pathways of Mir-1-3p in Colorectal Carcinoma Based on 645ï¿½cases from 9 Microarray Datasets

Jie‑Yu Wang,Jia‑Cheng Huang,Gang Chen,Dan‑Ming Wei

DOI: https://doi.org/10.3892/mmr.2018.8532

IF: 3.423

2018-01-01

Molecular Medicine Reports

Abstract:For the purpose of demonstrating the clinical value and unraveling the molecular mechanisms of micro RNA (miR)-1-3p in colorectal carcinoma (CRC), the present study collected expression and diagnostic data from Gene Expression Omnibus (GEO), ArrayExpress and existing literature to conduct meta‑analyses and diagnostic tests. Furthermore, the potential targets of miR‑1‑3p were attained from datasets that transfected miR‑1‑3p into CRC cells, online prediction databases and differentially expressed genes from The Cancer Genome Atlas and literature. Subsequently, bioinformatics analysis was conducted based on the aforementioned selected target genes. As a result, downregulation of miR‑1‑3p was observed. The combined standardized mean difference was ‑0.51 with 95% confidence interval (CI) of ‑0.68 to ‑0.33 using a fixed effect model, which demonstrated a significant downregulation of miR‑1‑3p in CRC. The combined sensitivity, specificity, positive likelihood ratio, negative likelihood ratio diagnostic score and odds ratio were 0.74 (95%CI: 0.48, 0.90), 0.75 (95%CI: 0.35, 0.94), 2.94 (95%CI: 1.01, 8.55), 0.34 (95%CI: 0.19, 0.60), 2.15 (95%CI: 1.06, 3.23) and 8.57 (95%CI: 2.89, 25.36). The summarized receiver operating characteristic curve demonstrated that the area under the curve was 0.81. In bioinformatics analyses based on 30 promising targets, the most enriched terms in Gene Ontology were positive regulation of transcription from RNA polymerase II promoter, extracellular region and transcription factor binding. Kyoto Encyclopedia of Genes and Genomes pathway analysis highlighted the pathway termed cytokine‑cytokine receptor interaction. In protein‑protein interaction analysis, platelet factor 4 was selected as the hub gene. To conclude, miR‑1‑3p is downregulated in CRC and likely suppresses CRC via multiple biological approaches, which indicates the diagnostic potential and tumor suppressive efficacy.
MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro.

Jingtian Liu,Zongyou Chen,Jianbin Xiang,Xiaodong Gu

DOI: https://doi.org/10.3892/ol.2018.8069

2018-01-01

Oncology Letters

Abstract:Colorectal cancer is one of the most common malignancies. Aberrant expressed microRNAs (miRNAs) have been demonstrated to have strong associations with colorectal cancer by repressing their targets. Therefore, miRNAs are thought to have significant promise in the diagnosis and prognosis of colorectal cancer. Previous studies indicated that miR-155 and collagen triple helix repeat containing 1 (CTHRC1) were both involved in pathogenesis of colorectal cancer, but the underlying mechanisms of miR-155 and CTHRC1 are still unknown. The present study aimed to investigate the biological functions of miR-155 and CTHRC1 in colorectal cancer. Reverse transcription-quantitative polymerase chain reaction was used to examine miR-155 and CTHRC1 expression levels. A dual-luciferase reporter assay was applied to verify the target interaction between miR-155 and CTHRC1. Proliferation, cell cycle, apoptosis, cell migration and invasion were measured using the MTT assay, flow cytometry and Transwell assays, respectively. Results showed that miR-155 expression was decreased, but CTHRC1 expression was increased in colorectal cancer tissue and cell lines. Furthermore, it was demonstrated that miR-155 negatively regulated CTHRC1. Additionally, miR-155 overexpression suppressed cell proliferation, induced cell cycle arrest and promoted cell apoptosis, while an inhibitor of miR-155 facilitated cell proliferation and cell cycle and repressed apoptosis. Transwell experiments indicated that miR-155 inhibited the cell migratory and invasive abilities of HT-29 cells, but miR-155 inhibitor enhanced these abilities of HT-29 cells. These results suggested that miR-155 prevented colorectal cancer progression and metastasis via silencing CTHRC1 in vitro, which provides evidence for miR-155 and CTHRC1 as a novel anti-onco molecular target for the treatment of colorectal cancer in the future.
The relationship between miR-219-5p Gene Polymorphisms and the prognosis of colorectal cancer

Yang Yan,Xiaohui Du,Shaoyou Xia,Songyan Li,Da Teng,Shidong Hu,Yufeng Wang,Rong Li

DOI: https://doi.org/10.21203/rs.3.rs-30253/v1

2020-01-01

Abstract:Abstract Background Colorectal cancer (CRC) is one of the most common malignant tumors, its morbidity and mortality are increasing year by year, it is a serious threat to people's health. Some studies have reported that miR-219-5p acts as a tumor suppressor in some malignant tumors. So the purpose of this study was to investigate the prognostic value of miR-219-5p expression in CRC patients. Methods QRT-PCR was used to detect the expression levels of miR-219-5p in CRC tissues and corresponding normal tissues (P < 0.001). The prognostic value of miR-219-5p in CRC was analyzed by Kaplan-Meier and Cox regression analysis. Results The results indicated that the expression of miR-219-5p was significantly lower in CRC tissues, and its expression was closely correlated with tumor differentiation, TNM staging and lymph node metastasis (all P < 0.05). Moreover, Kaplan Meier survival analysis showed that the patients with low expression of miR-219-5p had worse overall survival rates (P < 0.05). Cox regression analysis further demonstrated that miR-219-5p expression was an independent prognostic factor for survival time in CRC patients (P = 0.018, HR = 2.026 and 95%CI: 1.127–3.643). Conclusions All the results suggest that miR-219-5p expression can be used as a potential prognostic biomarker for CRC patients.
Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

Qingguo Li,Xin Liang,Yuwei Wang,Xianke Meng,Ye Xu,Sanjun Cai,Zhimin Wang,Jianwen Liu,Guoxiang Cai

DOI: https://doi.org/10.1038/srep27157

IF: 4.6

2016-01-01

Scientific Reports

Abstract:MicroRNAs (miRNAs) are important regulators involved in various cancers, including colorectal cancer (CRC). The functions and mechanisms of the miRNAs involved in CRC progress and metastasis are largely unknown. In this study, miRNA microarray analysis was performed to screen crucial miRNAs involved in CRC progress, and miR-139-5p was chosen for further study. The functional roles of miR-139-5p in colon cancer were demonstrated by CCK-8 proliferation assay, cell invasion and migration, cell apoptosis and in a KO mouse study. miR-139-5p expression was significantly decreased in cancer tissues compared to normal tissues. The miR-139-5p expression level was associated with tumour stage (P < 0.01). Function studies revealed that miR-139-5p was significantly correlated with the metastasis potential and drug resistance of colon cancer cells by affecting the epithelial-mesenchymal transition (EMT). Then, we identified BCL2 as a direct target of miR-139-5p cells in vitro. The patient samples and KO mice model showed that BCL2 expression was inversely correlated with the expression of miR-139-5p. In conclusion, we found that miR-139-5p targeted the BCL2 pathway to reduce tumour metastasis and drug sensitivity in CRC. This axis provided insight into the mechanism underlying miRNA regulation of CRC metastasis and a novel therapeutic target for CRC therapy.
Mir-494 Is An Independent Prognostic Factor And Promotes Cell Migration And Invasion In Colorectal Cancer By Directly Targeting Pten

Hai-Bing Sun,Xi Chen,Hong Ji,Tao Wu,Hong-Wei Lu,Yan Zhang,Hua Li,Yi-Ming Li

DOI: https://doi.org/10.3892/ijo.2014.2665

2014-01-01

International Journal of Oncology

Abstract:Accumulating evidence has shown that microRNAs (miRNAs) are involved in multiple processes in cancer development and progression. Upregulation of miRNA-494 (miR-494) has been identified as an oncogenic miRNA and is associated with poor prognosis in several types of human cancer. However, the specific function of miR-494 in colorectal cancer remains unclear. In this study we found that the expression of miR-494 in colorectal cancer tissues and cell lines was much higher than in normal control tissues and cells, respectively. In addition, upregulation of miR-494 more frequently occurred in tissue specimens with adverse clinical stage and the presence of distant metastasis. Moreover, multivariate survival analyses demonstrated that overexpression of miR-494 is an independent prognostic factor for both progression-free and overall survival. In addition miR-494 promoted invasion and migration in colorectal cancer cells, and miR-494 directly inhibited the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expression by targeting its 3'-untranslated region (3'-UTR). Moreover, PTEN is down regulated and inversely correlated with miR-494 expression in tissues. Thus, for the first time, we provided convincing evidence that upregulation of miR-494 was associated with tumor aggressiveness and tumor metastasis and promoted cell migration and invasion by targeting PTEN gene in colorectal cancer, and miR-494 is an independent prognostic marker for colorectal cancer patients.
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9

Petra Vychytilova-Faltejskova,Jana Merhautova,Tana Machackova,Irene Gutierrez-Garcia,José Garcia-Solano,Lenka Radova,Dominika Brchnelova,Katerina Slaba,Marek Svoboda,Jana Halamkova,Regina Demlova,Igor Kiss,Rostislav Vyzula,Pablo Conesa-Zamora,Ondrej Slaby

DOI: https://doi.org/10.1038/s41389-017-0006-6

2017-11-01

Oncogenesis

Abstract:Growing evidence suggests that microRNAs are involved in the development and progression of colorectal cancer (CRC). In the present study, deregulation and functioning of tumor-suppressive miR-215-5p was evaluated in CRC. In total, 448 tumor tissues and 325 paired adjacent healthy tissues collected from Czech and Spain cohorts of CRC patients have been used for miR-215-5p expression analyses. A series of in vitro experiments have been performed using transient transfection of miR-215-5p mimics into four CRC cell lines to identify specific cellular processes affected by miR-215-5p. Further, the effects of miR-215-5p on tumor growth were evaluated in vivo using NSG mice and stable cell line overexpressing miR-215-5p. Target mRNAs of miR-215-5p were tested using luciferase assay and western blot analyses. We found that miR-215-5p is significantly downregulated in tumor tissues compared with non-tumor adjacent tissues and its decreased levels correlate with the presence of lymph node metastases, tumor stage, and shorter overall survival in CRC patients. Overexpression of miR-215-5p significantly reduced proliferation, clonogenicity, and migration of CRC cells, lead to cell cycle arrest in G2/M phase and p53-dependent induction of apoptosis. The ability of miR-215-5p to inhibit tumor growth was confirmed in vivo. Finally, we confirmed epiregulin and HOXB9 to be the direct targets of miR-215-5p. As epiregulin is EGFR ligand and HOXB9 is its transcriptional inducer, we suggest that the main molecular link between miR-215-5p and CRC cells phenotypes presents the EGFR signaling pathway, which is one of the canonical pathogenic pathways in CRC.

oncology
IDDF2018-ABS-0183 P53-induced MIR-1249 suppresses tumour progression by targeting VEGFA and HMGA2 in colorectal cancer

Xiaoxiang Chen,Shukui Wang

DOI: https://doi.org/10.1136/gutjnl-2018-IDDFabstracts.22

IF: 24.5

2018-01-01

Gut

Abstract:Background MicroRNAs (miRNAs) are an important class of functional regulators involved in human cancers development, including colorectal cancer (CRC). Exploring aberrantly expressed miRNAs may provide us with new insights into the initiation and development of CRC by functioning as oncogenes or tumour suppressors. The aim of our study is to discover the expression pattern of miR-1249 in CRC and investigate its clinical significance as well as a biological role in CRC progression. Methods QRT-PCR was used to detect the relative expression of miR-1249 in CRC tissues and cell lines. EdU, CCK-8, Wound healing, transwell and HUVECs tube formation assays were performed to assess the effect of miR-1249 on CRC cell proliferation, migration, invasion and angiogenesis in vitro , nude mouse xenograft, tail vein injection and chicken chorioallantoic membrane(CAM) model were used to observe CRC growth, metastasis and angiogenesis in vivo . Luciferase reporter assay, western blot, immunohistochemistry(IHC) and immunofluorescence(IF) staining were fulfilled to explore the molecular mechanism of miR-1249 in CRC. Results MiR-1249 was found to be markedly downregulated in CRC tissues and cell lines. The expression of miR-1249 was negatively related to pN stage, pM stage, TNM stage and overall survival(OS). Moreover, we found that miR-1249 was a direct transcriptional target of P53 and revealed that P53-induced miR-1249 inhibited tumour growth, metastasis and angiogenesis in vitro and vivo. Additionally, we verified that miR-1249 suppressed CRC proliferation and angiogenesis by targeting VEGFA as well as inhibited CRC metastasis by targeting VEGFA and HMGA2. Further studying showed that miR-1249 suppressed CRC cell proliferation, migration, invasion and angiogenesis via VEGFA-mediated Akt/mTOR pathway as well as inhibited EMT process of CRC cells by targeting VEGFA and HMGA2. Conclusions Our study demonstrated that P53-induced miR-1249 might suppress CRC growth, metastasis and angiogenesis by targeting VEGFA and HMGA2, as well as regulate Akt/mTOR pathway and EMT process in the initiation and development of CRC. miR-1249 might be a novel the therapeutic candidate target in CRC treatment.
DNA-methylation-mediated Silencing of Mir-486-5p Promotes Colorectal Cancer Proliferation and Migration Through Activation of PLAGL2/IGF2/β-catenin Signal Pathways

Xiangxiang Liu,Xiaoxiang Chen,Kaixuan Zeng,Mu Xu,Bangshun He,Yuqin Pan,Huiling Sun,Bei Pan,Xueni Xu,Tao Xu,Xiuxiu Hu,Shukui Wang

DOI: https://doi.org/10.1038/s41419-018-1105-9

2018-01-01

Cell Death and Disease

Abstract:As one of the most common cancers worldwide, colorectal cancer (CRC) causes a large number of mortality annually. Aberrant expression of microRNAs (miRNAs) is significantly associated with the initiation and development of CRC. Further investigations regarding the regulatory mechanism of miRNAs is warranted. In this study, we discovered that miR-486-5p was remarkably downregulated in CRC, which partially results from higher DNA methylation in the promoter region detected by using methylation-specific PCR, bisulfite sequencing PCR, and DNA demethylation treatment. Besides, decreased miR-486-5p was obviously associated with advanced TNM stage, larger tumor size, lymphatic metastasis, and poor prognosis in CRC. Upregulated miR-486-5p inhibited the proliferation and migration of CRC through targeting PLAGL2 expression and subsequent repressing IGF/β-catenin signal pathways both in vitro and in vivo. Notably, plasma miR-486-5p expression was significantly upregulated in CRC patients and we identified plasma miR-486-5p as a novel diagnostic biomarker of CRC using receiver operating characteristic (ROC) curve analysis. Moreover, exploration in GEO dataset revealed that circulating miR-486-5p is tumor derived through being packaged into secretory exosomes. Taken together, our data demonstrated that miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathway, which is a promising therapeutic target of CRC treatment.
MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN

Guangjun Zhang,He Zhou,Huaxu Xiao,Zuoliang Liu,Hongpeng Tian,Tong Zhou

DOI: https://doi.org/10.1007/s10620-013-2858-8

2013-09-12

Digestive Diseases and Sciences

Abstract:BackgroundOur previous studies show that microRNA-92a (miR-92a) is overexpressed in colorectal cancer (CRC) and is thought to be correlated with the development of the cancer. However, its biological role in CRC remains poorly understood.AimsThe aim of the study was to determine the role of miR-92a and to elucidate its regulatory mechanism in CRC.MethodsThe expression levels of miR-92a and phosphatase and tensin homologue (PTEN) were detected by qRT-PCR and western blot. MTT, migration and invasion assays were used to examine the proliferation, migration and invasion of pre-miR-92a transfected SW480 cells, and a mouse model was used to investigate tumorigenesis. In addition, the regulation of PTEN by miR-92a was evaluated by qRT-PCR, western blot and luciferase reporter assays.ResultsThe expression of miR-92a was significantly up-regulated in the tissues of CRC patients with lymph node metastasis. The ectopic expression of miR-92a enhanced CRC cell proliferation, migration and invasion. Similar results were found in xenograft assay performed in nude mice. Up-regulation of miR-92a induced EMT in CRC cells. There was an inverse correlation between the levels of miR-92a and PTEN in CRC tissues. The overexpression of miR-92a in CRC cells decreased PTEN expression at the translational level, and decreased PTEN-driven luciferase-reporter activity.ConclusionsOur results demonstrated that miR-92a induced EMT and regulated cell growth, migration and invasion in the SW480 cells, at least partially, via suppression of PTEN expression. MiR-92a may serve as a novel therapeutic target in colorectal cancer.

gastroenterology & hepatology
Prognostic value and potential regulatory relationship of miR‐200c‐5p in colorectal cancer

Jiying Lu,Zhekang Jin,Xihan Jin,Wenbin Chen

DOI: https://doi.org/10.1002/jbt.23770

IF: 3.568

2024-07-19

Journal of Biochemical and Molecular Toxicology

Abstract:Abstract This study aimed to investigate the relationship and potential mechanisms of miR‐200c‐5p in colorectal cancer (CRC) progression. Differentially expressed miRNAs were screened using the TCGA database. Subsequently, univariate analysis was performed to identify CRC survival‐related miRNAs. Survival and receiver operator characteristic curves were generated. The target genes of miR‐200c‐5p and the relevant signaling pathways or biological processes were predicted by the miRNet database and enrichment analyses. The miR‐200c‐5p expression was detected using quantitative reverse‐transcription polymerase chain reaction, Cell Counting Kit‐8, Transwell, and cell apoptosis experiments were performed to determine miR‐200c‐5p's impact on CRC cell viability, invasiveness, and apoptosis. Finally, we constructed a CRC mouse model with inhibited miR‐200c‐5p to evaluate its impact on tumors. miR‐200c‐5p was upregulated in CRC, implying a favorable prognosis. Gene set enrichment analysis revealed that miR‐200c‐5p may participate in signaling pathways such as the TGF‐β signaling pathway, RIG‐I‐like receptor signaling pathway, renin‐angiotensin system, and DNA replication. miR‐200c‐5p potentially targeted mRNAs, including KCNE4 and CYP1B1, exhibiting a negative correlation with their expression. Furthermore, these mRNAs may participate in biological processes like the regulation of intracellular transport, cAMP‐dependent protein kinase regulatory activity, ubiquitin protein ligase binding, MHC class II protein complex binding, and regulation of apoptotic signaling pathway. Lastly, miR‐200c‐5p overexpression repressed the viability and invasiveness of CRC cells but promoted apoptosis. The tumor size, weight, and volume were significantly increased by inhibiting miR‐200c‐5p ( p < 0.05). miR‐200c‐5p is upregulated in CRC, serving as a promising biomarker for predicting CRC prognosis.

biochemistry & molecular biology,toxicology

Expression and clinical significance of miR-17-5p in tumor tissues of patients with colorectal cancer

Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer

Elevated Oncofoetal Mir-17-5p Expression Regulates Colorectal Cancer Progression by Repressing Its Target Gene P130

The expression and clinical significance of miR-647 in colon cancer cells

miR-215 expression and its clinical significance in advanced colorectal cancer

Biology of Human Tumors miR-2045 p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB 22 A

Mir-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.

MicroRNA-142-3p Inhibits Tumorigenesis of Colorectal Cancer via Suppressing the Activation of Wnt Signaling by Directly Targeting to β-Catenin

P53-induced Mir-1249 Inhibits Tumor Growth, Metastasis, and Angiogenesis by Targeting VEGFA and HMGA2

Clinical and Biological Significance of Mir-378a-3p and Mir-378a-5p in Colorectal Cancer

Expression level and potential target pathways of miR-1-3p in colorectal carcinoma based on 645 cases from 9 microarray datasets.

Expression Level and Potential Target Pathways of Mir-1-3p in Colorectal Carcinoma Based on 645ï¿½cases from 9 Microarray Datasets

MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro.

The relationship between miR-219-5p Gene Polymorphisms and the prognosis of colorectal cancer

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

Mir-494 Is An Independent Prognostic Factor And Promotes Cell Migration And Invasion In Colorectal Cancer By Directly Targeting Pten

MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9

IDDF2018-ABS-0183 P53-induced MIR-1249 suppresses tumour progression by targeting VEGFA and HMGA2 in colorectal cancer

DNA-methylation-mediated Silencing of Mir-486-5p Promotes Colorectal Cancer Proliferation and Migration Through Activation of PLAGL2/IGF2/β-catenin Signal Pathways

MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN

Prognostic value and potential regulatory relationship of miR‐200c‐5p in colorectal cancer